Shuttle Pharmaceuticals Holdings, Inc. - Director's Change in Common Stock Ownership

The SEC filing reports a change in the ownership of common stock by Sachin Pathigoda Arachchige, a director of Shuttle Pharmaceuticals Holdings, Inc. The filing indicates that as of September 12, 2025, Sachin Pathigoda Arachchige no longer holds any shares of common stock in the company. The transaction was reported on October 28, 2025. This filing is significant as it reflects a change in the ownership structure of the company, particularly involving a key director.